← Back to Search

Other

Ketogenic Diet for Alcohol Metabolism (KAM Trial)

Phase 2 & 3
Recruiting
Led By Corinde Wiers, Ph.D.
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 hours
Awards & highlights

KAM Trial Summary

This trial will study the effects of ketosis and alcohol on brain functioning using MRI scans and other measurements.

Who is the study for?
This trial is for healthy individuals who have consumed at least two alcoholic drinks on one occasion in the past month. They must be willing to follow study procedures and diets, not exceed a weight of 225lbs, and can't be using medications or substances that affect the study. Pregnant or breastfeeding women, those with certain medical conditions or psychiatric disorders, and anyone with MRI contraindications are excluded.Check my eligibility
What is being tested?
The study tests how a ketogenic diet affects brain function during ketosis and after consuming alcohol (4-5 beverages). Participants will undergo three different dietary interventions over three days each: a ketogenic diet, ethanol intake, ketone supplements, versus a control diet. Brain activity is monitored using MRI scans.See study design
What are the potential side effects?
Potential side effects may include discomfort from dietary changes such as nausea or constipation due to the ketogenic diet; intoxication symptoms from alcohol consumption; reactions to ketone supplements like stomach upset; and possible claustrophobia or discomfort during an MRI scan.

KAM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in breath alcohol concentration
Secondary outcome measures
Change in cognitive performance tasks
Change in motor agility tasks

KAM Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Ketone supplementExperimental Treatment2 Interventions
Eat a control diet for 3 days with a ketone supplement drink
Group II: Ketogenic dietExperimental Treatment1 Intervention
Eat a ketogenic diet for 3 days
Group III: Alcohol InterventionExperimental Treatment3 Interventions
Alcohol lab, participants will receive ethanol drinks that are dose-adjusted for body weight and sex differences in pharmacokinetics and calculated to obtain a final breath alcohol concentration of 0.08%
Group IV: Control DietPlacebo Group1 Intervention
Eat a control diet for 3 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ethanol
2005
Completed Phase 4
~3000

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,882,267 Total Patients Enrolled
5 Trials studying Metabolic Syndrome
642 Patients Enrolled for Metabolic Syndrome
Kyle Kampman, MDStudy DirectorUniversity of Pennsylvania
3 Previous Clinical Trials
185 Total Patients Enrolled
Henry Kranzler, MDStudy DirectorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limitation for participation in this trial?

"As indicated by the inclusion criteria, qualified applicants must be between 21 and 50 years old. 38 medical studies are available for those under 18 while 247 exist for participants over 65."

Answered by AI

For whom is enrollment available in this research project?

"Candidates who are 21 - 50 years old and have a history of alcohol consumption may qualify for this clinical trial. In total, 20 people will be accepted to participate in the study."

Answered by AI

Are there presently openings for study participants in this trial?

"According to clinicaltrials.gov, this medical experiment has not been recruiting since September 29th 2023 and is no longer actively searching for participants. However, there are still 356 other trials in search of patients at present."

Answered by AI
~11 spots leftby Dec 2025